42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
    [defid] => VWS-WOO-08-1244245
    [request_id] => 
)

=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
    [id] => 4fcaa35f-8cc2-44d5-9a7e-9cc56e50cd1f
    [Document ID] => 1244245
    [Document naam] => RE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15 March 15:00 - 16:30CET: Thromboembolic events reported following vaccination with the COVID-19Vaccine AstraZeneca
    [Bestandsnaam] => 
    [Beoordeling] => 
    [Beoordelingsgrond] => 
    [Toelichting] => 
    [Publieke link] => 
    [Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/document/VWS-WOO-08-1244245
    [Opgeschort] => 
    [Definitief ID] => VWS-WOO-08-1244245
    [Status] => 
    [FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo
    [DocumentPublicationDate] => 15 maart 2021
    [DocumentStatusCheckedDate] => 
    [DocumentStatusCheckedResult] => 
    [SourceFileType] => 
    [Tags] => 
    [Besluit] => 
    [ModifiedDate] => 2025-09-22 08:09:19
    [DeletedDate] => 
    [BesluitURL] => 
    [CreatedDate] => 2025-06-19 18:31:59
    [DocumentDownloadLink] => 
    [DigestLaatsteControleDatum] => 2025-09-22 08:09:19
)

Document: VWS-WOO-08-1244245

Pagina 1 preview
Klik om te vergroten

Document correcties

Geregistreerde datum: 20210315

Geregistreerde documentnaam: RE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15 March 15:00 - 16:30CET: Thromboembolic events reported following vaccination with the COVID-19Vaccine AstraZeneca

Document metadata

Metadata tonen (25 velden)
VeldWaarde
id4fcaa35f-8cc2-44d5-9a7e-9cc56e50cd1f
Document ID1244245
Document naamRE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15 March 15:00 - 16:30CET: Thromboembolic events reported following vaccination with the COVID-19Vaccine AstraZeneca
Bestandsnaamleeg!
Beoordelingleeg!
Beoordelingsgrondleeg!
Toelichtingleeg!
Publieke linkleeg!
Locatie open.minvws.nlhttps://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/document/VWS-WOO-08-1244245
Opgeschortleeg!
Definitief IDVWS-WOO-08-1244245
Statusleeg!
FromFilehttps://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo
DocumentPublicationDate15 maart 2021
DocumentStatusCheckedDateleeg!
DocumentStatusCheckedResultleeg!
SourceFileTypeleeg!
Tagsleeg!
Besluitleeg!
ModifiedDate2025-09-22 08:09:19
DeletedDateleeg!
BesluitURLleeg!
CreatedDate2025-06-19 18:31:59
DocumentDownloadLinkleeg!
DigestLaatsteControleDatum2025-09-22 08:09:19

🧙 User tags

Nog geen user tags

Document attributen

TagWaardeDatum
document_SectionDownloadButton12025-09-02 07:58:24
About_Gelakte gegevens_linkhref_3mailto:DienstpostbusDatalekkenDoo@minvws.nl2025-09-02 07:58:24
About_Gelakte gegevens5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.2h De beveiliging van personen of bedrijven en het voorkomen van sabotage Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten2025-09-02 07:58:24
document_SectionHistory12025-06-22 23:45:23
About_Gelakte gegevens_linkhref_1https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-22 23:45:23
About_Gelakte gegevens_linkname_15.1.2e Eerbiediging van de persoonlijke levenssfeer2025-06-22 23:45:23
About_Gelakte gegevens_linkhref_2https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk52025-06-22 23:45:23
About_Gelakte gegevens_linkname_25.1.2h De beveiliging van personen of bedrijven en het voorkomen van sabotage2025-06-22 23:45:23
About_Gelakte gegevens_linkhref_3mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over RE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15 March 15:00 - 16:30CET: Thromboembolic events reported following vaccination with the COVID-19Vaccine AstraZeneca (documentnummer 1eec1b43-3681-62be-b44a-bb3705657b16)2025-06-22 23:45:23
About_Gelakte gegevens_linkname_3Laat het ons weten2025-06-22 23:45:23
document_SectionRequest12025-06-22 23:45:23
Request_Onderdeel vanWoo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 20212025-06-22 23:45:23
Request_Onderdeel van_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo2025-06-22 23:45:23
Request_Onderdeel van_linkname_1Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode maart 20212025-06-22 23:45:23
Request_Samenvatting verzoekDe minister van Volksgezondheid, Welzijn en Sport heeft op 23 november 2023 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties & Medicatie maart 2021.2025-06-22 23:45:23
Request_PeriodeMaart 20212025-06-22 23:45:23
Request_Type besluitWoo-besluit2025-06-22 23:45:23
Request_Datum besluit23 november 20232025-06-22 23:45:23
Request_Omvang openbaarmaking15.961 documenten, 29.047 pagina's Inventarislijst2025-06-22 23:45:23
Request_Omvang openbaarmaking_documenten15.9612025-06-22 23:45:23
Request_Omvang openbaarmaking_paginas29.0472025-06-22 23:45:23
Request_Omvang openbaarmaking_linkhref_1https://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/inventory2025-06-22 23:45:23
Request_Omvang openbaarmaking_linkname_1Inventarislijst2025-06-22 23:45:23
About_Download alsPDF (1.21 MB)2025-06-22 23:45:23
document_documentNameRE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15 March 15:00 - 16:30CET: Thromboembolic events reported following vaccination with the COVID-19Vaccine AstraZeneca2025-06-22 23:45:23
document_documentTypeE-mailbericht2025-06-22 23:45:23
document_documentPublicationDate2021-03-152025-06-22 23:45:23
document_documentNumberVWS-WOO-08-12442452025-06-22 23:45:23
document_SectionDownloadButton02025-06-22 23:45:23
document_SectionHTMLDataDivs32025-06-22 23:45:23
document_SectionAbout12025-06-22 23:45:23
About_Datum document15 maart 20212025-06-22 23:45:23
About_Type bronbestandE-mailbericht, 3 pagina's2025-06-22 23:45:23
About_Type bronbestand_paginas32025-06-22 23:45:23
About_Documentnummer12442452025-06-22 23:45:23
About_BeoordelingGedeeltelijke openbaarmaking2025-06-22 23:45:23
About_Gelakte gegevens5.1.2e Eerbiediging van de persoonlijke levenssfeer 5.1.2h De beveiliging van personen of bedrijven en het voorkomen van sabotage Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten.2025-06-22 23:45:23
History Datum_130 mei 2024 19:162025-06-21 06:27:34
History Actie_3Bronbestand vervangen (pdf, 1.21 MB)2025-06-21 06:27:34
History Datum_430 mei 2024 18:192025-06-21 06:27:34
History Actie_4Bronbestand vervangen (pdf, 1.21 MB)2025-06-21 06:27:34
History Datum_530 mei 2024 16:492025-06-21 06:27:34
History Actie_5Bronbestand vervangen (pdf, 1.21 MB)2025-06-21 06:27:34
History Datum_630 mei 2024 16:352025-06-21 06:27:34
History Actie_6Bronbestand vervangen (pdf, 1.21 MB)2025-06-21 06:27:34
History Datum_730 mei 2024 15:012025-06-21 06:27:34
History Actie_7Bronbestand vervangen (pdf, 1.21 MB)2025-06-21 06:27:34
History Datum_830 mei 2024 14:492025-06-21 06:27:34
History Actie_8Bronbestand toegevoegd (pdf, 1.21 MB)2025-06-21 06:27:34
History Datum_230 mei 2024 19:112025-06-21 06:27:34
History Actie_1Bronbestand vervangen (pdf, 1.21 MB)2025-06-21 06:27:34
History Datum_330 mei 2024 18:342025-06-21 06:27:34
History Actie_2Bronbestand vervangen (pdf, 1.21 MB)2025-06-21 06:27:34
DocumentDownload_linknameDownload (pdf, 1.21 MB)2025-04-19 21:10:29
DocumentDownload_linkhrefhttps://open.minvws.nl/dossier/VWS-WOO/3661708-1052463-pdo/file/download/document/1eec1b43-3681-62be-b44a-bb3705657b162025-04-19 21:10:29
DocumentDownload_proposed_filename (lokale kopie)VWS-WOO-08-1244245.pdf2025-04-19 21:10:29

Archiefversies (6 rijen)

Archiefrij 1 — 2025-09-07 17:25:08
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-1244245.pdf
documentName: VWS-WOO-08-1244245.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 1273871
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:25:08
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:25:08
lastSeen: 2025-09-07 17:25:08
text: 1244245 5.1.2e es12e To: 5.1.2e EE)IEEE@inv ni]From: 5.1.2 Sent: Mon 3/15/2021 4:29:02 PM Subject: RE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15March 15:00-16:30CET: Thromboembolic events reported following vaccination with theCOVID-19Vaccine AstraZeneca Received:Mon 3/15/2021 4:29:02 PM Enjijook...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 54b77cd39048efbec9550949955b61ffbca93e2b6bde7b348e2d6c11281c0f69
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: folder_import_44539_d405b2d59b638d18a026842c5332dc82
textDigestSHA256: b50cc5c27fc055f9694f166f18a8becf50c42f6202a8591225c813dc7b14518f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1244245
Archiefrij 2 — 2025-09-04 17:12:23
fromFile: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip
documentName: VWS-WOO-08-1244245.pdf
documentType: pdf
documentCompressedSize: 813610
documentSize: 1273871
documentCompressRatio: 63.869104485462024
documentDateModified: 2025-05-01 20:45:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:12:23
lastSeen: 2025-09-04 17:12:23
text: 1244245 5.1.2e es12e 5.1.2e From: 5.1.2 Sent: Mon 3/15/2021 4:29:02 PM EE) @ inv ni] IEEE To: Subject: RE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15 March 15:00 reported following vaccination with the COVID-19Vaccine AstraZeneca - 16:30CET: Thromboembolic eve...
noTextDate: leeg!
ocrText: 1227720 Artikel ArtikeIType, ArtikelFarmaceut ArtikelDescription ArtikelCategorie ArtikelAantal ArtikelEenheid, ArtikelHoeveelheid, ArtikelHoeveelheid Flacons,ArtikelHoeveelheidDosesPerTray ArtikelHoeveelheidDoses, ArtikelAfnemer ArtikelAfnemerGroep, ArtikelAfgiftedatum , ArtikelStatus, ArtikelAfze...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 54b77cd39048efbec9550949955b61ffbca93e2b6bde7b348e2d6c11281c0f69
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3661708-1052463-pdo-1f026c98-ad58-69b6-b436-65673e0af118.zip_6155
textDigestSHA256: 34beef56158eb97630612f1ace8371482a9c90951df63869a7b8086abf5508fc
ocrTextDigestSHA256: cbb318e36bc801b51a4e835f266ccf9e2f2591f7587882f9cceab6e8131f83fb
extractedId: VWS-WOO-08-1244245
Archiefrij 3 — 2025-09-04 17:10:20
fromFile: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
fromFilePath: ../../archieven_files/VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip
documentName: VWS-WOO-08-1244245.pdf
documentType: pdf
documentCompressedSize: 813610
documentSize: 1273871
documentCompressRatio: 63.869104485462024
documentDateModified: 2025-05-01 20:45:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 17:10:20
lastSeen: 2025-09-04 17:10:20
text: 1244245 5.1.2e es12e 5.1.2e From: 5.1.2 Sent: Mon 3/15/2021 4:29:02 PM EE) @ inv ni] IEEE To: Subject: RE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15 March 15:00 reported following vaccination with the COVID-19Vaccine AstraZeneca - 16:30CET: Thromboembolic eve...
noTextDate: leeg!
ocrText: isoweek-2021 isoweek-2022 |Ct-waarde 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-09 2022-...
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 54b77cd39048efbec9550949955b61ffbca93e2b6bde7b348e2d6c11281c0f69
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: VWS-WOO-3661708-1052463-pdo-1f019da5-31c3-6fd4-91a7-fda7571a98e0.zip_6155
textDigestSHA256: 34beef56158eb97630612f1ace8371482a9c90951df63869a7b8086abf5508fc
ocrTextDigestSHA256: 34ea7743594f08b217c2e155c1f4035ef17e172d69327d310aa73507055b967b
extractedId: VWS-WOO-08-1244245
Archiefrij 4 — 2025-03-18 09:30:26
fromFile: 2024.075-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1244245-RE_EU-EEA_NITAG_COLLABORATION_WEBINAR_MONDAY_15_March_1500_-_1630CET_Thromboembolic_events_reported_following_vaccination_with_the_COVID-19Vaccine_AstraZeneca.pdf
documentType: pdf
documentCompressedSize: 811568
documentSize: 1273871
documentCompressRatio: 63.70880567969598
documentDateModified: 2024-10-25 13:30:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:26
lastSeen: 2025-03-18 09:30:26
text: 1244245 5.1.2e es12e To: 5.1.2e EE)IEEE@inv ni]From: 5.1.2 Sent: Mon 3/15/2021 4:29:02 PM Subject: RE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15March 15:00-16:30CET: Thromboembolic events reported following vaccination with theCOVID-19Vaccine AstraZeneca Received:Mon 3/15/2021 4:29:02 PM Enjijook...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b50cc5c27fc055f9694f166f18a8becf50c42f6202a8591225c813dc7b14518f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 355038
textDigestSHA256: b50cc5c27fc055f9694f166f18a8becf50c42f6202a8591225c813dc7b14518f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1244245
Archiefrij 5 — 2025-02-27 09:25:06
fromFile: 2022.252-VWS-WOO-3661708-1052463-pdo.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2022.252-VWS-WOO-3661708-1052463-pdo.zip
documentName: VWS-WOO-08-1244245-RE_EU-EEA_NITAG_COLLABORATION_WEBINAR_MONDAY_15_March_1500_-_1630CET_Thromboembolic_events_reported_following_vaccination_with_the_COVID-19Vaccine_AstraZeneca.pdf
documentType: pdf
documentCompressedSize: 811568
documentSize: 1273871
documentCompressRatio: 63.70880567969598
documentDateModified: 2024-10-25 13:30:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:06
lastSeen: 2025-02-27 09:25:06
text: 1244245 5.1.2e es12e To: 5.1.2e EE)IEEE@inv ni]From: 5.1.2 Sent: Mon 3/15/2021 4:29:02 PM Subject: RE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15March 15:00-16:30CET: Thromboembolic events reported following vaccination with theCOVID-19Vaccine AstraZeneca Received:Mon 3/15/2021 4:29:02 PM Enjijook...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 391, "email": "EEA.pe@minvws.nl", "context": "2021 3:14 PM Aan:EEA.pe@minvws.nl> Onderwerp: FW: EU-EEA"}]
documentMailAdresses: [{"position": 391, "email": "EEA.pe@minvws.nl", "context": "2021 3:14 PM Aan:EEA.pe@minvws.nl> Onderwerp: FW: EU-EEA"}]
digestSHA256: b50cc5c27fc055f9694f166f18a8becf50c42f6202a8591225c813dc7b14518f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: 268208
textDigestSHA256: b50cc5c27fc055f9694f166f18a8becf50c42f6202a8591225c813dc7b14518f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1244245
Archiefrij 6 — 2025-02-18 12:18:04
fromFile: Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-8b6498f524850c599dea15620ecff89d59609350ff716d119d38634615d4d862.zip
documentName: VWS-WOO-08-1244245-RE_EU-EEA_NITAG_COLLABORATION_WEBINAR_MONDAY_15_March_1500_-_1630CET_Thromboembolic_events_reported_following_vaccination_with_the_COVID-19Vaccine_AstraZeneca.pdf
documentType: pdf
documentCompressedSize: 811568
documentSize: 1273871
documentCompressRatio: 63.70880567969598
documentDateModified: 2024-10-25 13:30:06
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:04
lastSeen: 2025-02-18 12:18:04
text: 1244245 5.1.2e es12e To: 5.1.2e EE)IEEE@inv ni]From: 5.1.2 Sent: Mon 3/15/2021 4:29:02 PM Subject: RE: EU-EEA NITAG COLLABORATION WEBINAR MONDAY 15March 15:00-16:30CET: Thromboembolic events reported following vaccination with theCOVID-19Vaccine AstraZeneca Received:Mon 3/15/2021 4:29:02 PM Enjijook...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: [{"position": 391, "email": "EEA.pe@minvws.nl", "context": "2021 3:14 PM Aan:EEA.pe@minvws.nl> Onderwerp: FW: EU-EEA"}]
documentMailAdresses: [{"position": 391, "email": "EEA.pe@minvws.nl", "context": "2021 3:14 PM Aan:EEA.pe@minvws.nl> Onderwerp: FW: EU-EEA"}]
digestSHA256: b50cc5c27fc055f9694f166f18a8becf50c42f6202a8591225c813dc7b14518f
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 57344
textDigestSHA256: b50cc5c27fc055f9694f166f18a8becf50c42f6202a8591225c813dc7b14518f
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-1244245

(dit is ook een speeltuin)